Press Releases

Hogan Lovells represents Novartis in Collaboration and Exclusive Option Agreement with IFM Therapeutics

International law firm Hogan Lovells team advised Swiss pharmaceuticals company Novartis in a collaboration and option agreement with IFM Due, a subsidiary of Boston-based biopharmaceutical ...

Press Releases

Hogan Lovells Represents LabCorp in Net US$485 Million Complex Strategic Acquisition and Divestiture

New York, Washington D.C., 17 April 2019 – Hogan Lovells is representing LabCorp, a leading global life sciences company, in a complex two-way acquisition and divestiture transaction...

Press Releases

Hogan Lovells helps Novartis expand immunotherapy portfolio with acquisition IFM Tre

New York, 2 April 2019 – A cross-practice team of lawyers from international law firm Hogan Lovells is advising pharmaceutical company Novartis on its acquisition of IFM Tre, a...

News

ACER’s future is getting brighter

7 June 2017 - Who’s Who Legal recently released its inaugural Future Leaders for Competition listing and it features seven of our antitrust and competition rising stars. Partners Logan...

Loading data